L & S Advisors Inc Novo Nordisk A S Transaction History

L & S Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$122.71 - $146.91 $382,118 - $457,477	-3,114 Reduced 4.7%	63,072 $9 Million
Q1 2024 May 10, 2024	BUY	$102.11 - $135.92 $66,167 - $88,076	648 Added 0.99%	66,186 $8.5 Million
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $2.13 Million - $2.56 Million	-24,288 Reduced 27.04%	65,538 $6.78 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $8.17 Million - $17.9 Million	89,826 New	89,826 $8.17 Million
Q4 2021 Feb 09, 2022	SELL	$95.88 - $117.08 $796,283 - $972,349	-8,305 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$84.42 - $106.62 $701,108 - $885,479	8,305 New	8,305 $797,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $252B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.